North America Clinic Casting and Splinting Products Market

The North America clinic casting and splinting products market is expected to grow from US$ 567.48 million in 2022 to US$ 869.47 million by 2030. It is estimated to grow at a CAGR of 5.5% from 2022 to 2030.   

Rising Prevalence of Musculoskeletal Conditions Fuels North America Clinic Casting and Splinting Products Market

According to the World Health Organization (WHO) musculoskeletal conditions are the leading cause of disability across the world, and low back pain is the single leading cause of disability in 160 countries. Musculoskeletal disorders ranked first in years lived with disability (YLDs) and sixth in disability-adjusted life-years (DALYs) globally in 2019. According to WHO, ∼1.71 billion people across the world had musculoskeletal conditions in 2021. According to a study titled “Global prevalence of musculoskeletal disorders among physiotherapists: a systematic review and meta-analysis” published in the National Library of Medicine, there has been an increase in the incidence of musculoskeletal diseases in the US.

Rheumatoid arthritis (RA), osteoarthritis (OA), low-back pain (LBP), and neck pain (NP) are a few common musculoskeletal conditions. According to an article published by Springer Nature in 2023, rheumatoid arthritis, one of the main autoimmune rheumatic diseases, affects 14 million people worldwide. Joint pain is the most common reason for specialist referrals. Cast or splint is used in the management of various musculoskeletal conditions. To maximize benefits while minimizing complications, the use of casts and splints is generally limited to the short term. Thus, the rising incidence of musculoskeletal conditions is driving the growth of the North America clinic casting and splinting products market.

North America Clinic Casting and Splinting Products Market Overview

The North America clinic casting and splinting products market has been segmented into the US, Canada, and Mexico; being the major contributors to the market growth in this region. The North America casting and splinting market is growing because of the rising rates of osteoporosis and musculoskeletal injuries and increased rates of age-related orthopedic disorders brought on by the growing geriatric population. Furthermore, carefully thought-out reimbursement regulations enable access to pricey casting and splinting equipment, supporting market growth.

According to the United States Bone and Joint Initiative (USBJI), musculoskeletal diseases affect nearly three out of four people aged 65 and over and one in every two persons aged 18 and above in the US. According to Centers for Disease Control and Prevention (CDC), in 2019, 54.1 million US adults were 65 or older, representing 16% of the population. By 2040, the number of older adults is expected to reach 80.8 million. By 2060, it will reach 94.7 million, and older adults will make up nearly 25% of the US population. Orthopedic injuries are common in the aging population due to biological changes in older adults’ bodies. As people grow older, their bone mineral density decreases. Musculoskeletal diseases are becoming a greater burden every year with the aging US population. One of the serious problems facing the elderly is fractures. Moreover, osteoporosis, a metabolic bone disease that causes reduced mineral density and quality of bone, is a significant health and economic burden in the US. Fractures can occur in any bone; however, hip and spine fractures are the most common, accounting for 42% of all osteoporotic fractures. More than 700,000 vertebral body compression fractures occur per year in the United States. In the US, one in two women over 50 have an osteoporosis-related bone break in their lifetime.

The management of a wide variety of musculoskeletal conditions requires the use of a cast or splint. Splints are noncircumferential immobilizers that accommodate swelling. This quality makes splints ideal for the management of a variety of acute musculoskeletal conditions in which swelling is anticipated, such as acute fractures or sprains or initial stabilization of reduced, displaced, or unstable fractures before orthopedic intervention. Thus, the rising prevalence of musculoskeletal conditions and osteoporosis will boost the demand for casting and splinting products in the US.

North America Clinic Casting and Splinting Products Market Revenue and Forecast to 2030 (US$ Million)

North America Clinic Casting and Splinting Products Strategic Insights

Strategic insights for the North America Clinic Casting and Splinting Products provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Clinic Casting and Splinting Products Report Scope

North America Clinic Casting and Splinting Products Regional Insights

The geographic scope of the North America Clinic Casting and Splinting Products refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Clinic Casting and Splinting Products Market Segmentation

The North America clinic casting and splinting products market is segmented into product, application, material, and country.

Based on product, the North America clinic casting and splinting products market is segmented into casting and splinting. The casting segment held a larger share of the North America clinic casting and splinting products market in 2022. The casting is sub-segmented into casts, tapes, cutters, and casting accessories. The splinting segment is further segmented into splints and splinting accessories.

Based on application, the North America clinic casting and splinting products market is segmented into acute fractures or sprains, tendon and ligament injuries, and others. The acute fractures segment held the largest share of the North America clinic casting and splinting products market in 2022.

Based on material, the North America clinic casting and splinting products market is segmented into Plaster of Paris, fiberglass, and others. The Plaster of Paris segment held the largest share of the North America clinic casting and splinting products market in 2022.

Based on country, the North America clinic casting and splinting products market is segmented into the US, Canada, and Mexico. The US dominated the North America clinic casting and splinting products market in 2022. 

3M Co, Corflex Inc, DeRoyal Industries Inc, Dynatronics Corporation, Enovis Corp, Essity AB, Ossur hf, Performance Health Holding Inc, and Zimmer Biomet Holdings Inc are some of the leading companies operating in the North America clinic casting and splinting products market.